Home > Quotes > PRGO

Perrigo Company Stock Quote & Summary Data

PRGO 
$120.09
*  
1.07
  negative  
0.88%
Get PRGO Alerts
*Delayed - data as of Jun. 19, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

1 Year Target: 128
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. 597,499
Previous Close: $ 121.16
52 Week High /Low: $ 121.33 / $ 98.79
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 11,293,152,036
P/E Ratio: 26.34
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 21.60
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 4.56
Annualized dividend $ 0.36
Ex Dividend Date May 29, 2013
Dividend Payment Date Jun. 18, 2013
Current Yield 0.3 %
Beta 0.78

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

ETFs with PRGO as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.29% SPDR S&P Pharmaceuticals ETF (XPH) +11.99  (19.90%)
3.57% iShares NASDAQ Biotechnology Index Fund (IBB) +31.86  (22.02%)
3.22% iShares Dow Jones U.S. Pharmaceutical Index Fund (IHE) +12.92  (14.28%)
2.47% PowerShares Dynamic Heathcare (PTH) +6.21  (19.11%)
1.81% First Trust NASDAQ-100 Ex-Technology Sector Index Fund (QQXT) +2.76  (11.29%)

We make it easy to follow the leaders. PowerShares QQQ. 100 companies at the top of innovation in one fund.


*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

**Green highlights the top performing ETF by % change in the past 100 days.

 Company Description (as filed with the SEC)

Perrigo Company, established in 1887, is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, infant formulas, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is the world’s largest store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company’s primary markets and locations of manufacturing and logistics operations are the United States (U.S.), Israel, Mexico, the United Kingdom (U.K.) and Australia. See Note 17 of the Notes to Consolidated Financial Statements for further information. Perrigo Company operates through several wholly owned subsidiaries. In the U.S., its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., Perrigo Holland, Inc. (formerly J.B. Laboratories, Inc.  ... More ...  



News Headlines for PRGO

Perrigo in Expansion Mode - Analyst Blog
6/18/2013 12:10:01 PM - Zacks.com
Perrigo Acquires Ophthalmic Product Portfolio From Fera Pharma
6/17/2013 8:47:00 AM - RTT News
Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
6/17/2013 8:33:00 AM - PR Newswire
Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
6/17/2013 8:33:00 AM - PR Newswire
Cartoons & Contraceptives? Pitching Plan B to Teens
6/13/2013 4:02:00 PM - Fox Business
 

Consensus Recommendation